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Hitting the hot spots of cell 
signaling cascades with small 
molecules
Th e guanosine family of triphosphate-binding proteins 
(G proteins), such as Rho, Rac, and Ras, are signaling molecules 
involved in regulation of cell proliferation, cell survival, and 
cytoskeletal organization. Th e Gβγ subunit of these G proteins is 
released upon ligand activation of G protein-coupled receptors. 
Free Gβγ subunits bind and regulate multiple target proteins 
within the cell. Hundreds of cell surface receptors for hormones 
and other extracellular factors activate G proteins, thereby 
regulating nearly all aspects of cell physiology. Small molecules 
that negatively or positively modulate the protein–protein 
interactions of G proteins could likewise be powerful therapeutic 
agents. However, drugs that target protein–protein interfaces 
are harder to develop than those that target the active sites of 
enzymes. Many of the protein interfaces tend to be adaptive, 
meaning that a signaling protein can use some surface to bind 
to a structurally diverse set of targets. One way to overcome 
at least some of these hurdles is to identify compounds that 
target the so-called ‘hot spot’ of the protein–protein interface. 
Th at is what Bonacci and his colleagues have successfully 
done.1 Th e researchers performed virtual docking of a small-
molecule library to a site on Gβγ subunits that mediate 
protein interactions. Th ey hypothesized that diff erential 
targeting of this surface could allow for selective modulation 
of Gβγ-subunit functions. Several compounds bound to Gβγ 
subunits with affi  nities from 0.1 to 60 mM and selectively 
modulated functional Gβγ protein–protein interactions in vitro, 
chemotactic peptide signaling pathways in HL-60 leukocytes, 
and opioid receptor-dependent analgesia in vivo. Th ese data 
demonstrate an approach for specifi c modulation of G protein-
coupled receptor signaling that may represent an important 
therapeutic strategy.2 Th ere is still a long way to go before the 
Gβγ-binding sites of compounds can be accurately defi ned. 
Nevertheless, the hunting season for drugs that target other G-
protein interfaces has now begun. (1Science 2006; 312: 443–446. 
2Science 2006; 312: 377–378)
Marc De Broe
Loss of ACE2 causes 
glomerulosclerosis in male mice
Angiotensin-converting enzyme-2 (ACE2), a membrane-
bound carboxymonopeptidase highly expressed in the 
kidney, functions as a negative regulator of the renin–
angiotensin system. In a recent issue of the American 
Journal of Pathology, Oudit et al. reported that male ACE2 
mutant (ACE2–/y) mice developed early accumulation of 
fi brillar collagen in the glomerular mesangium followed 
by glomerulosclerosis by 12 months of age. Female ACE2 
mutant (ACE2–/–) mice were relatively protected from 
glomerulosclerosis. Progressive kidney injury was associated 
with increased deposition of collagen I, collagen III, and 
fi bronectin in the glomeruli and increased urinary albumin 
excretion as compared with those in age-matched control 
mice. Treatment with the angiotensin II type-1 receptor 
antagonist irbesartan prevented these structural and 
functional changes in the glomeruli of male ACE2 mutant 
mice. Loss of ACE2 was associated with an increased 
formation of renal lipid peroxidation products and activation 
of mitogen-activated protein kinase and extracellular signal-
regulated kinases 1 and 2 in glomeruli. Th ese events were 
also prevented by angiotensin II type-1 receptor blockade. 
Th e authors conclude that deleting the ACE2 gene leads 
to angiotensin II-dependent glomerular injury in male Targeting the Gβγ bull’s-eye.
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Glomerular immunohistochemical profile of 1-year-old ACE2+/y and 
ACE2–/y mice.
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mice. Th ese fi ndings have important implications for our 
understanding of ACE2, the renin–angiotensin system, and 
gender in renal injury. ACE2 is likely to be an important 
therapeutic target in kidney disease. (Am J Pathol 2006; 168: 
1808–1820)
Detlef Schlöndorﬀ 
WNK1 kinase regulation of renal 
potassium excretion
Th e WNK family of serine/threonine kinases is important 
as a modulator of renal sodium reabsorption and potassium 
excretion. Mutations in the WNK4 or the WNK1 gene cause 
a familial disorder (pseudohypoaldosteronism type II) of 
diminished renal potassium excretion, excessive sodium 
retention, and hypertension. Molecular reconstitution 
studies in Xenopus oocytes showed that wild-type WNK4 
inhibits the NaCl cotransporter (NCC) and the secretory 
potassium channel Kir1.1. Alternative splicing of the WNK1 
gene produces a ubiquitous long form (L-WNK1) and a 
kidney-specifi c short form of WNK1 (KS-WNK1). It was 
previously found that the L-WNK1 blocked the inhibitory 
eff ect of WNK4 on the NCC, restoring Na transport activity 
to near normal levels. However, the action of WNK1 
isoforms on potassium handling has been unclear. In a new 
study, Wade et al. showed that KS-WNK1 and L-WNK1 
converge in a pathway to regulate the renal outer-medullary 
K+ channel, Kir1.1. In reconstitution studies using Xenopus 
oocytes, they found that L-WNK1 signifi cantly inhibited 
Kir1.1 by reducing cell surface localization of the channel. 
Interestingly, a catalytically inactive L-WNK1 mutant had no 
inhibitory eff ect on Kir1.1, indicating that channel inhibition 
depends on kinase activity. Th e KS-WNK1 isoform, which 
lacks a kinase domain, did not directly alter Kir1.1. Instead, 
KS-WNK1 negatively regulated L-WNK1 to release Kir1.1 
from inhibition. Acute dietary potassium loading increased 
the relative abundance of KS-WNK1 to L-WNK1 transcript 
and protein in the kidney, indicating that physiological 
upregulation of Kir1.1 activity involves a WNK1 isoform 
switch and KS-WNK1-mediated release from L-WNK1 
inhibition. Th us, the results of Wade et al. provide evidence 
for the physiological regulation of renal K+ excretion by a 
kinase isoform switch mechanism. (Proc Natl Acad Sci USA 
2006; 103: 8558–8563)
Juan Oliver
Arachidonate monooxygenases 
and salt-sensitive hypertension
Th e metabolism of endogenous arachidonic acids 
(AAs) to epoxyeicosatrienoic acids (EETs) and 20-
hydroxyeicosatetraenoic acid by the epoxygenase and 
ω-hydroxylase branches of the cytochrome P450 AA 
monooxygenase is well established. Earlier studies identifi ed 
members of the cytochrome P450 CYP2C and CYP4A 
gene subfamilies as functionally relevant AA epoxygenases 
and ω-hydroxylases, respectively, and implicated them 
in the control of renal function and blood pressure. 
However, the unequivocal interpretation of these studies 
was complicated by the in vitro nature of the data and/or 
genetic complexity of the animal models studied. In their 
paper, Nakagawa et al. showed that disruption of the murine 
cytochrome P450, family 4, subfamily a, polypeptide 10 
(Cyp4a10) gene caused dietary salt-sensitive hypertension. 
Cyp4a10–/– mice fed low-salt diets were normotensive but 
became hypertensive when fed normal or high-salt diets. 
Hypertensive Cyp4a10–/– mice had a dysfunctional kidney 
epithelial sodium channel (ENaC) and became normotensive 
when given amiloride, a selective inhibitor of this sodium 
channel. Th ese studies establish a physiological role for the 
arachidonate monooxygenases in renal sodium reabsorption 
and blood pressure regulation. Th ey also demonstrate that 
a dysfunctional Cyp4a10 gene causes alterations in the 
gating activity of ENaC. Although the mechanism by which 
products of the Cyp4a10 gene regulate renal epoxygenase 
expression remains to be defi ned, the authors propose that 
during balanced salt intake and excretion, locally generated 
EETs participate in ENaC gating and the regulation of 
distal sodium reabsorption. Diet-induced increases in 
plasma sodium cause compensatory volume changes and 
epoxygenase-mediated responses. Augmented EET levels 
cause inactivation of ENaC, reduction in inward sodium 
transport, and increased sodium excretion, and, conversely, 
reductions in epoxygenase increase ENaC-dependent 
sodium reabsorption, expansion of the plasma volume, and 
hypertension. (J Clin Invest 2006; 116: 1696–1702)
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Role of the WNK1 kinase isoform switch in the regulation of distal-
nephron K and Na transport.
W
ad
e 
et
 a
l./
Pr
oc
 N
at
l A
ca
d 
Sc
i U
SA
